摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-3-氯苯乙酮盐酸盐 | 51084-83-4

中文名称
2-氨基-3-氯苯乙酮盐酸盐
中文别名
2-氨基-3'-氯苯乙酮盐酸盐
英文名称
2-amino-1-(3-chlorophenyl)ethanone hydrochloride
英文别名
2-amino-1-(3-chlorophenyl)ethanone;hydrochloride
2-氨基-3-氯苯乙酮盐酸盐化学式
CAS
51084-83-4
化学式
C8H8ClNO*ClH
mdl
——
分子量
206.072
InChiKey
ORPJIXJTXWDVRY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    222 °C

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    43.1
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2922399090
  • 储存条件:
    室温

SDS

SDS:e92a6759ea036a63f3d86030286fab43
查看

反应信息

  • 作为反应物:
    描述:
    2-氨基-3-氯苯乙酮盐酸盐碳酸氢钠 作用下, 以 甲醇乙醇乙腈 为溶剂, 反应 50.0h, 生成
    参考文献:
    名称:
    将抗氟康唑的真菌与新型β-唑-苯丙酮衍生物进行抗药性。
    摘要:
    设计并合成了一系列具有新颖结构的β-唑-苯丙酮衍生物,以抵抗易感真菌感染和耐药真菌感染的增加。评估了合成化合物对五种敏感菌株和五种耐氟康唑的菌株的抗真菌活性。抗真菌活性测试表明,大多数化合物对5种病原菌株均表现出优异的抗真菌活性,其MIC值在0.03-1μg/ mL的范围内。R1 = 3-F取代且15o和15ae的化合物对MIC范围为1-8μg/ mL的耐氟康唑耐药菌株17#和CaR表现出中等的抗真菌活性。R1 = H或2-F(例如15a,15o,15p)的化合物对耐氟康唑的菌株632具有中等至良好的抗真菌活性,901和904的MIC值在0.125-4μg/ mL的范围内。值得注意的是,15o和15ae对五种敏感菌株和五种对氟康唑耐药的菌株均表现出抗真菌活性。初步的机理研究表明,化合物15ae的有效抗真菌活性源于对白色念珠菌CYP51的抑制作用。化合物15o,15z和15ae对哺乳动物A549细胞几乎无毒。
    DOI:
    10.1016/j.ejmech.2019.111689
  • 作为产物:
    描述:
    (3-chloro-phenyl)-glyoxal-2-oxime盐酸乙醚 、 tin(ll) chloride 作用下, 生成 2-氨基-3-氯苯乙酮盐酸盐
    参考文献:
    名称:
    Edkins; Linnell, Quarterly Journal of Pharmacy and Pharmacology, 1936, vol. 9, p. 75,102
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
    申请人:——
    公开号:US20030207913A1
    公开(公告)日:2003-11-06
    The invention provides compounds of Formula I: Azabicyclo-N(R 1 )—C(═X)—W  Formula I These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    这项发明提供了Formula I的化合物: Azabicyclo-N(R1)—C(═X)—W  Formula I 这些化合物可以是药用盐或组合物的形式,或者是它们的消旋混合物,或者是纯对映体。Formula I的化合物在已知涉及α7的药物中是有用的。
  • COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
    申请人:Sakagami Masahiro
    公开号:US20110028468A1
    公开(公告)日:2011-02-03
    This invention provides a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is substituted or unsubstituted alkyl or the like, R 2 is hydrogen or substituted or unsubstituted alkyl, Ring A is monocyclic or bicyclic aromatic heterocycle, R 3 is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted heterocycle, R 4 is halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl or the like, m is an integer between 0 and 2, n is an integer between 0 and 5, R is halogen, oxo, cyano, nitro, substituted or unsubstituted alkyl or the like, and p is an integer between 0 and 2 as novel compounds having NPY Y5 antagonistic activity.
    这项发明提供了式(I)的化合物: 其药学上可接受的盐或溶剂化合物, 其中 R1为取代或未取代的烷基或类似物, R2为氢或取代或未取代的烷基, 环A为单环或双环芳香杂环, R3为取代或未取代的芳基,取代或未取代的杂芳基或取代或未取代的杂环, R4为卤素,氰基,取代或未取代的烷基,取代或未取代的环烷基或类似物, m为0到2之间的整数, n为0到5之间的整数, R为卤素,氧代,氰基,硝基,取代或未取代的烷基或类似物,以及 p为0到2之间的整数 作为具有NPY Y5拮抗活性的新化合物。
  • [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
    申请人:GLAXOSMITHKLINE LLC
    公开号:WO2010059658A1
    公开(公告)日:2010-05-27
    The invention is directed to 6-(4-pyιϊmidinyl)-1 H-indazole derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R1 - R4 are defined herein. The compounds of the invention are inhibitors of PDK1 and can be useful in the treatment of immune and metabolic diseases and disorders characterized by constitutively activated ACG kinases such as cancer and more specifically cancers of the breast, colon, and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting PDK1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    这项发明涉及6-(4-吡咯嗪基)-1 H-吲唑衍生物。具体而言,该发明涉及符合式(I)的化合物,其中R1-R4在此处被定义。该发明的化合物是PDK1的抑制剂,可用于治疗由于恒定激活的ACG激酶所特征化的免疫和代谢性疾病和紊乱,如癌症,更具体地说是乳腺癌、结肠癌和肺癌。因此,该发明进一步涉及包括该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包括该发明化合物的药物组合物来抑制PDK1活性和治疗相关疾病的方法。
  • Discovery of 1-(5-(1H-benzo[d]imidazole-2-yl)-2,4-dimethyl-1H-pyrrol-3-yl)ethan-1-one derivatives as novel and potent bromodomain and extra-terminal (BET) inhibitors with anticancer efficacy
    作者:Bo Kong、Zhaohong Zhu、Hongmei Li、Qianqian Hong、Cong Wang、Yu Ma、Wan Zheng、Fei Jiang、Zhimin Zhang、Ting Ran、Yuanyuan Bian、Na Yang、Tao Lu、Jiapeng Zhu、Weifang Tang、Yadong Chen
    DOI:10.1016/j.ejmech.2021.113953
    日期:2022.1
    modifications led to the identification of compound 35f as the most active inhibitor of BET BRD4 with selectivity against BET family proteins. Further biological studies revealed that compound 35f can arrest the cell cycle in G0/G1 phase and induce apoptosis via decreasing the expression of c-Myc and other proteins related to cell cycle and apoptosis. More importantly, compound 35f showed favorable pharmacokinetic
    作为表观遗传阅读器,溴结构域和末端外结构域 (BET) 家族蛋白与组蛋白中的乙酰化赖氨酸残基结合并募集蛋白质复合物以促进转录起始和延伸。通过小分子抑制剂抑制 BET 溴结构域已成为一种有前途的癌症治疗策略。在这里,我们描述了我们为发现一系列新的 1-(5-(1 H -benzo[ d ]imidazole-2-yl)-2,4-dimethyl-1 H -pyrrol-3-yl)ethan 所做的努力-1-one 衍生物作为 BET 抑制剂。密集的结构修饰导致化合物35f被鉴定为对 BET 家族蛋白具有选择性的最活跃的 BET BRD4 抑制剂。进一步的生物学研究表明,化合物35f通过降低c-Myc等细胞周期和细胞凋亡相关蛋白的表达,使细胞周期停滞在G 0 /G 1期,诱导细胞凋亡。更重要的是,化合物35f在 MV4-11 小鼠异种移植模型中显示出良好的药代动力学特性和抗肿瘤功效,具有可接受的耐受性。这些结果表明,BET
  • Insecticidal hydrazine derivatives
    申请人:Nihon Nohyaku Co., Ltd.
    公开号:US05608109A1
    公开(公告)日:1997-03-04
    The present invention relates to a hydrazine derivative represented by the formula (I): ##STR1## (wherein each of Ar.sup.1 and Ar.sup.2 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted heteroaryl group, or the like, R.sup.1 is an alkyl group or the like, and A is a divalent radical having --C.dbd.N--N-- or --CH--NH--N-- as a fundamental skeleton), which is a useful compound as an agricultural and horticultural insecticide.
    本发明涉及一种由以下式(I)表示的肼衍生物:##STR1##(其中Ar.sup.1和Ar.sup.2中的每一个是取代或未取代的苯基,取代或未取代的杂环基等,R.sup.1是烷基等,A是具有--C.dbd.N--N--或--CH--NH--N--作为基本骨架的二价基团),该化合物是一种用作农业和园艺杀虫剂的有用化合物。
查看更多